Abiopharma

News list

(99% Neutral) MANNKIND CORP (MNKD) Reports Q2 2022 Financial Results

Full text

News bot Oct. 1, 2025, 9:52 p.m.
📋 MANNKIND CORP (MNKD) - Financial Results

Filing Date: 2022-05-23

Accepted: 2022-05-23 16:06:06

Event Type: Financial Results
Event Details:
MannKind Corporation (MNKD) Reports Q2 2022 Financial Results MannKind Corporation (MNKD) announced its financial results for the period ending Q2 2022. Key Financial Highlights:

Revenue: Not disclosed

Net Income: Not disclosed

EPS: Not disclosed

Cash and equivalents: Not disclosed
anticipated in such forward-looking statements as a result of various risks and uncertainties, which include risks and uncertainties regarding the satisfaction of closing conditions for the Asset Purchase and our estimates regarding personnel needs for the V-Go® business. Additional risks are detailed in the Company’s filings with the Securities and Exchange Commission (“SEC”), including under the heading “Risk Factors” in MannKind’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2022
📊 Key Financial Metrics:

Metric Value
💼 Business Developments:
- Partnership
- Acquisition: Not available
- Licensing: Not available
- Regulatory Approval: Not available
- Executive Changes: Not available
Structured Data:
- Company Name: MannKind Corporation
- CIK: 0000899460
- Ticker Symbol: MNKD
- Period End Date: 2022-05-17
- Document Type: 8-K